Important concerns in the management of severe asthma identified at the European Respiratory Biologics Forum
| How can biomarkers and phenotypes be best identified and utilised in daily clinical practice? |
| Is the ACQ the right tool for monitoring the response to biologics? |
| Is treatment response assessed using the ACQ related to the effect of treatment on exacerbations? |
| How can awareness be raised among patients and non-specialists regarding the burden of oral corticosteroids and the potential of new treatments available? |
| Are oral steroids effective in patients having exacerbations while on biological therapies? |
| When should patients start and stop taking a biologic? |
| When should patients be switched from one biologic to another? |
ACQ: Asthma Control Questionnaire.